Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Potential mechanisms of resistance to cytarabine in AML patients.
Galmarini CM, Thomas X, Calvo F, Rousselot P, El Jafaari A, Cros E, Dumontet C. Galmarini CM, et al. Among authors: rousselot p. Leuk Res. 2002 Jul;26(7):621-9. doi: 10.1016/s0145-2126(01)00184-9. Leuk Res. 2002. PMID: 12008078
In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.
Galmarini CM, Thomas X, Calvo F, Rousselot P, Rabilloud M, El Jaffari A, Cros E, Dumontet C. Galmarini CM, et al. Among authors: rousselot p. Br J Haematol. 2002 Jun;117(4):860-8. doi: 10.1046/j.1365-2141.2002.03538.x. Br J Haematol. 2002. PMID: 12060121 Free article.
Hypersensitivity pneumonitis related to imatinib mesylate.
Bergeron A, Bergot E, Vilela G, Ades L, Devergie A, Espérou H, Socié G, Calvo F, Gluckman E, Ribaud P, Rousselot P, Tazi A. Bergeron A, et al. Among authors: rousselot p. J Clin Oncol. 2002 Oct 15;20(20):4271-2. doi: 10.1200/JCO.2002.99.179. J Clin Oncol. 2002. PMID: 12377975 No abstract available.
Acute monocytic leukemia presenting as acute respiratory failure.
Azoulay E, Fieux F, Moreau D, Thiery G, Rousselot P, Parrot A, Le Gall JR, Dombret H, Schlemmer B. Azoulay E, et al. Among authors: rousselot p. Am J Respir Crit Care Med. 2003 May 15;167(10):1329-33. doi: 10.1164/rccm.200206-554OC. Epub 2003 Feb 5. Am J Respir Crit Care Med. 2003. PMID: 12574074
Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia.
Raffoux E, Rousselot P, Poupon J, Daniel MT, Cassinat B, Delarue R, Taksin AL, Réa D, Buzyn A, Tibi A, Lebbé G, Cimerman P, Chomienne C, Fermand JP, de Thé H, Degos L, Hermine O, Dombret H. Raffoux E, et al. Among authors: rousselot p. J Clin Oncol. 2003 Jun 15;21(12):2326-34. doi: 10.1200/JCO.2003.01.149. J Clin Oncol. 2003. PMID: 12805334 Clinical Trial.
Relationship between elevated levels of the alpha 1 acid glycoprotein in chronic myelogenous leukemia in blast crisis and pharmacological resistance to imatinib (Gleevec) in vitro and in vivo.
Larghero J, Leguay T, Mourah S, Madelaine-Chambrin I, Taksin AL, Raffoux E, Bastie JN, Degos L, Berthaud P, Marolleau JP, Calvo F, Chomienne C, Mahon FX, Rousselot P. Larghero J, et al. Among authors: rousselot p. Biochem Pharmacol. 2003 Nov 15;66(10):1907-13. doi: 10.1016/s0006-2952(03)00469-6. Biochem Pharmacol. 2003. PMID: 14599548
Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.
Terre C, Eclache V, Rousselot P, Imbert M, Charrin C, Gervais C, Mozziconacci MJ, Maarek O, Mossafa H, Auger N, Dastugue N, Talmant P, Van den Akker J, Leonard C, N'Guyen Khac F, Mugneret F, Viguié F, Lafage-Pochitaloff M, Bastie JN, Roux GL, Nicolini F, Maloisel F, Vey N, Laurent G, Recher C, Vigier M, Yacouben Y, Giraudier S, Vernant JP, Salles B, Roussi J, Castaigne S, Leymarie V, Flandrin G, Lessard M; France Intergroupe pour la Leucemie Myeloide Chronique. Terre C, et al. Among authors: rousselot p. Leukemia. 2004 Aug;18(8):1340-6. doi: 10.1038/sj.leu.2403399. Leukemia. 2004. PMID: 15190256
320 results